ANTIHYPERTENSIVE AND RENAL EFFECTS OF ENALAPRIL AND SLOW-RELEASE VERAPAMIL IN ESSENTIAL-HYPERTENSION - A DOUBLE-BLIND, RANDOMIZED STUDY

被引:5
|
作者
FAGHER, B
HENNINGSEN, N
HULTHEN, L
KATZMAN, P
THULIN, T
机构
[1] UNIV LUND, MALMO GEN HOSP, DEPT MED, S-21401 MALMO, SWEDEN
[2] UNIV LUND, MALMO GEN HOSP, DEPT ENDOCRINOL, S-21401 MALMO, SWEDEN
关键词
Enalapril; hypertension; renal function; verapamil;
D O I
10.1007/BF01409207
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The renal, metabolic and antihypertensive effects of enalapril (E) and slow-release verapamil (V) were compared in a 2-month double-blind crossover trial in 22 patients with newly discovered essential hypertension. The glomerular filtration rate and renal vascular resistance were unaltered; renal blood flow was slightly decreased by V Serum Ca2+ increased and Na+ excretion declined after V. Serum lipids, glucose, and erythrocyte electrolytes were unchanged. Blood pressure (BP) was lower with E after half the maximum dosage compared with V but similar BP reductions were obtained after 2 months with the maximum dosage. © 1990 Springer-Verlag.
引用
收藏
页码:S41 / S43
页数:3
相关论文
共 50 条
  • [1] ANTIHYPERTENSIVE EFFICACY AND TOLERABILITY OF ENALAPRIL AND SLOW-RELEASE VERAPAMIL IN ESSENTIAL-HYPERTENSION - A DOUBLE-BLIND, CROSS-OVER STUDY
    FAGHER, B
    KATZMAN, P
    HULTHEN, UL
    HENNINGSEN, NC
    THULIN, T
    JOURNAL OF INTERNAL MEDICINE, 1991, 230 (03) : 219 - 226
  • [2] A RANDOMIZED, DOUBLE-BLIND THERAPEUTIC TRIAL OF ENALAPRIL VERSUS SLOW-RELEASE NIFEDIPINE IN MILD TO MODERATE ESSENTIAL-HYPERTENSION
    ARTIGOU, JY
    BENICHOU, M
    BERLAND, J
    FRESSINAUD, P
    GROLLIER, G
    GUERET, P
    DUC, LNC
    PRESSE MEDICALE, 1990, 19 (01): : 13 - 16
  • [3] A DOUBLE-BLIND-STUDY OF SLOW-RELEASE NIFEDIPINE AND DILTIAZEM IN MILD OR MODERATE ESSENTIAL-HYPERTENSION
    VILLAMIL, AS
    SARMIENTO, RA
    MICHELI, M
    MUCHINIK, E
    RODRIGUEZ, P
    VIOR, G
    MEDICINA-BUENOS AIRES, 1987, 47 (06) : 662 - 662
  • [4] A CONTROLLED RANDOMIZED DOUBLE-BLIND CROSSOVER STUDY OF THE EFFECTS OF ANTIHYPERTENSIVE PHARMACOTHERAPY AND HOMEOPATHY IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    HITZENBERGER, G
    KORN, A
    DORCSI, M
    BAUER, P
    WOHLZOGEN, FX
    WIENER KLINISCHE WOCHENSCHRIFT, 1982, 94 (24) : 665 - 670
  • [5] ENALAPRIL AND PROPRANOLOL IN ESSENTIAL-HYPERTENSION - A DOUBLE-BLIND COMPARATIVE-STUDY
    ARR, SM
    BARNES, JN
    BEEVERS, DG
    BRECKENRIDGE, AM
    BING, RF
    COOPER, WD
    CURRIE, WJC
    DAVIES, JR
    DREW, PJ
    GOODWIN, FJ
    GRIMMER, SFM
    KAPILA, H
    ORME, ML
    SKEHAN, JD
    THURSTON, H
    VANDENBURG, MJ
    WEISSBERG, PL
    WOOLLARD, ML
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (05) : P606 - P607
  • [6] A DOUBLE-BLIND COMPARATIVE-STUDY OF LISINOPRIL AND ENALAPRIL IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    JOHNSTON, GD
    BANKS, DC
    DAVIES, S
    DUFFIN, D
    GARNHAM, JC
    NICHOLLS, DP
    RAJ, MV
    MANSY, S
    SLOAN, P
    STROUTHIDIS, TM
    SULLIVAN, PA
    THURSTON, H
    VARMA, MP
    WATSON, RD
    WILKINSON, R
    JOURNAL OF HUMAN HYPERTENSION, 1991, 5 (05) : 405 - 410
  • [7] THE EFFECTS OF SLOW-RELEASE VERAPAMIL ON BLOOD-PRESSURE AND CARDIOVASCULAR-SYSTEM IN ESSENTIAL-HYPERTENSION
    MERIC, M
    ADALET, K
    ERZENGIN, F
    KORKUT, F
    OKUR, O
    BUYUKOZTURK, K
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 : S42 - S44
  • [8] ANTIHYPERTENSIVE EFFECT OF DILTIAZEM IN A SLOW-RELEASE FORMULATION FOR MILD TO MODERATE ESSENTIAL-HYPERTENSION
    NIKKILA, MT
    INKOVAARA, JA
    HEIKKINEN, JT
    OLSSON, SOR
    AMERICAN JOURNAL OF CARDIOLOGY, 1989, 63 (17): : 1227 - 1230
  • [9] ENALAPRIL VERSUS CAPTOPRIL - A DOUBLE-BLIND MULTICENTER COMPARISON IN ESSENTIAL-HYPERTENSION
    RUMBOLDT, Z
    MARINKOVIC, M
    DRINOVEC, J
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1988, 8 (03) : 181 - 188
  • [10] HYPERTENSION AND ARRHYTHMIAS - EFFECTS OF SLOW-RELEASE NICARDIPINE VS CHLORTHALIDONE - A DOUBLE-BLIND CROSSOVER STUDY
    GALDERISI, M
    CELENTANO, A
    TAMMARO, P
    GAROFALO, M
    MUREDDU, GF
    DEDIVITIIS, O
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1990, 28 (10) : 410 - 415